Toronto 2008 2018-02-06T18:28:57+00:00

Toronto 2008

Topics and Speakers

Opening Remarks on Learning Objectives – Presenters: Jim Kormos, VP CNETS Canada

Carcinoid 101 – IntroductionDr. Kjell Oberg, MD

Carcinoid 101 – Diagnosis of NETSDr. Richard R.P. Warner, MD

Biological Manifestation of NETSDr. Eugene Woltering, MD, FACS

Clinical Manifestations of NETSDr. Edward M. Wolin, MD

Classification and Pathology of NETsDr. Thomas O’Dorisio, MD

Lung Carcinoid – Different Solutions for Different Patients – Dr. Dan Granberg, MD

NeuroEndocrine Heart Issues – Dr. Bryan Dias, MD

NETs in Children and Young Adults – Dr. Sue O’Dorisio, MD, PhD

Nuclear Medicine Pertaining to NETs – Dr. Manoranjan Chowhan, MBBS, DRM, DNB, MNAMS

Hepatic Arterial Embolization – Dr. Irina Rachinsky, MD, MSc

Surgery for Pancreatic NETs – Dr. J. Philip Boudreaux, MD

Surgical Management of NETs Liver Metastases – Dr. Douglas Quan, MD

Palliative Surgery for Midgut Carcinoids – Dr. Janice L. Paseika, MD

Medical Therapy of Carcinoid NETs – Dr. Edward M. Wolin, MD

Chemotherapy of NETs – Dr. Walter Kocha, MD

Role of Interferon in Treating NETs – Dr. Kjell Oberg, MD

Somatostatin Analogues – Dr. Philippe Ruszniewski, MD

Challenges Sustaining a NETs Cancer Program – Dr. Brian Orr, Vice President, London Regional Cancer Program

Out of Country Program – Dr. Robert Thompson, Health Canada Special Access Program

Health Canada’s Special Access Program – Ian Mackay, Health Canada, Therapeutic Products Directorate

Imaging of Neuroendocrine Tumors – Dr. Mariel V. Fortier, MD

PET/CT in NeuroEndocrine Tumours – Prof. Richard Baum, MD

Radio-labelled Somatostatin Therapy – Dr. Muriel Buxton-Thomas, MD

Indium-131 MIBG Treatment – Dr. Ernst J. Postema, MD, PhD

Treatment of Metastatic Bone Pain – Dr. Robert Reid, MD, ChB, FRCPC

Hepatic Embolotherapy – Dr. David Liu, MD, FRCPC

Supportive NETs Experience in UK – Philippa Davies, RN, BN, MSc

Symptom Control & NETs – Dr. Michael Sanatani, MD

Optimizing Patient Therapies (Panel) – Robert Reid (moderator), Eugene Woltering, Ed Wolin, Muriel Buxton-Thomas, Richard Baum, J. Philip Boudreaux, Walter Kocha and Ernst J. Postema

Management of Hepatic Mets with Melphalan – Dr. James F. Pingpank, Jr., MD, FACS

Animal Models of Carcinoid & NETs Note: Selected slides have been edited out of the recorded presentation because the research data has not yet been published in official journals. – Dr. Girish M. Shah

Developing Effective Antiangiogenic Agents – Dr. Eugene Woltering, MD, FACS

International Faculty (listed alphabetically):

Prof. Joy Ardill, Belfast University, Belfast, Ireland
Prof. Dr. Richard P. Baum, Zentralklinik Bad Berka, Bad Berka, Germany
Dr. J. Philip Boudreaux, Louisiana State University, LA, US
Dr. Muriel Buxton-Thomas, King’s College Hospital, London, UK
Dr. Manoranjan Chowhan, Ruby Hall Clinic, Pune, India
Dr. Dan Granberg, University Hospital, Uppsala, Sweden
Prof. Kjell Oberg, Uppsala University, Sweden
Dr. M. Sue O’Dorisio, University Iowa, Iowa, US
Dr. Thomas O’Dorisio, University Iowa, Iowa, US
Dr. James Pingpank, NCI NIH Bethesda, MD
Dr. Philippe Ruszniewski, Hospital Beaujon, Clichy, France
Dr. Richard R.P. Warner, Mount Sinai School of Medicine, New York, NY, US
Dr. Edward M. Wolin, Cedars Sinai Medical Center, Los Angeles, CA, US
Dr. Eugene A. Woltering, Louisiana State University, LA, US

Canadian Faculty (listed alphabetically):

Dr. Bryan Dias, London Health Sciences Centre, London, Ontario
Dr Marielle Fortier, London Health Sciences Centre, Victoria Campus, London, Ontario.
Dr. Sherif Hanna, Sunnybrook Hospital, Toronto, Ontario
Dr. Walter Kocha, London Health Sciences Centre, London, Ontario
Dr. David Liu, University of British Columbia, Vancouver General Hospital, Vancouver, BC
Dr. Janice Pasieka, University of Calgary, Alberta
Dr. Ernst Postema, Department of Oncology, University of Alberta
Dr. Doug Quan, London Health Sciences Centre, London, Ontario
Dr. Irina Rachinsky, Nuclear Medicine Physician, London Health Sciences Centre, London, Ontario
Dr. Robert H. Reid, London Health Sciences Centre, London, Ontario
Dr. Michael Sanatani, London Health Sciences Centre, London, Ontario
Prof. Girish M. Shah, University Laval, Quebec City, Quebec
Dr. Simron Singh, Sunnybrook Hospital, Toronto, Ontario
Dr. Lillian Siu, Princess Margaret Hospital, Toronto, Ontario
Dr. Jean-Luc Urbain, Chief of Nuclear Medicine at University of Western Ontario, and London Health Sciences Centre, London, Ontario.
Dr. Stan VanUum, St. Josephs Hospital, London, Ontario
Dr. Ralph Wong, St. Boniface Hospital, Winnipeg, Manitoba

Guest Speakers:

Kathy Arbanasin, Chemist, Patient Support Leader, Northern California, US
Cathy Bouvier, NET Patient Foundation Patient Outreach Program, London, UK
Philippa Davies, Royal Free Hospital, Hampstead, London, UK
Ian Mackay, Health Canada Special Access Program
Brian Orr, Regional Vice President, London Regional Cancer Program, London Health Sciences Centre, London, Ontario
Suzanne Quirk, Radioisotope Technologist, London Health Sciences Centre, London, Ontario
Silvia Steinhilber, Treasurer CNETS Canada, Winnipeg Support Group Leader
Dana Sussman, Licensed Clinical Psychologist, Chicago, Ill, US
Robert Thomson, Medical Consultant, Out of Country Program for Ontario Health
Monica Warner, Development Officer, Carcinoid Cancer Foundation, New York, NY
Carol-Anne Wilson, Patient Advocate